SCM
Sio Capital Management Portfolio holdings
AUM
$249M
1-Year Return
117.71%
This Quarter Return
-18.78%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$261M
AUM Growth
+$26.1M
(+11%)
Cap. Flow
+$62.9M
Cap. Flow
% of AUM
24.14%
Top 10 Holdings %
Top 10 Hldgs %
37.23%
Holding
89
New
29
Increased
20
Reduced
14
Closed
14
Top Buys
| 1 |
Cencora
COR
|
$9.97M |
| 2 |
CVS Health
CVS
|
$9.49M |
| 3 |
Medtronic
MDT
|
$8.72M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$8.2M |
| 5 |
Novo Nordisk
NVO
|
$6.79M |
Top Sells
| 1 |
GSK
GSK
|
$14.6M |
| 2 |
AET
Aetna Inc
AET
|
$12.3M |
| 3 |
Kura Oncology
KURA
|
$8.19M |
| 4 |
Biogen
BIIB
|
$6.82M |
| 5 |
Elevance Health
ELV
|
$6.8M |
Sector Composition
| 1 | Healthcare | 95.45% |
| 2 | Technology | 0.48% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Merck
MRK
$210B
| – | – |
0
| – | – |
|
77
Novartis
NVS
$249B
| – | – |
-64,383
| Closed | -$4.97M |
|
78
Puma Biotechnology
PBYI
$257M
| – | – |
-32,832
| Closed | -$1.51M |
|
79
Pacira BioSciences
PCRX
$1.2B
| – | – |
0
| – | – |
|
80
Penumbra
PEN
$10.9B
| – | – |
0
| – | – |
|
81
Pfizer
PFE
$140B
| – | – |
0
| – | – |
|
82
Universal Health Services
UHS
$11.8B
| – | – |
-41,393
| Closed | -$5.29M |
|
|
NVRO
83
DELISTED
NEVRO CORP.
NVRO
| – | – |
-45,091
| Closed | -$2.57M |
|
|
ONCT
84
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| – | – |
0
| – | – |
|
|
SPPI
85
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| – | – |
-70,712
| Closed | -$1.19M |
|
|
AMAG
86
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| – | – |
0
| – | – |
|
|
AKCA
87
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| – | – |
0
| – | – |
|
|
AGN
88
DELISTED
Allergan plc
AGN
| – | – |
0
| – | – |
|
|
AET
89
DELISTED
Aetna Inc
AET
| – | – |
-60,444
| Closed | -$12.3M |
|